{"ticker": {"uuid": "8415711a-c576-4679-8100-d8e8af878e36", "symbol": "CTKB", "name": "Cytek Biosciences Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Cytek Biosciences (Nasdaq: CTKB) sets severance and consulting terms", "summary": "Cytek Biosciences has detailed the separation terms for its former Chief Legal Officer and Corporate Secretary, Valerie Barnett, whose tenure ended on June 29, 2026. The agreement includes a one-time severance payment of $365,775.12 and COBRA premium coverage, with enhanced benef", "url": "https://www.stocktitan.net/sec-filings/CTKB/8-k-cytek-biosciences-inc-reports-material-event-48c14d036f06.html", "source_name": "Stock Titan", "published_at": "2026-07-16T03:40:03", "published_display": "16 Jul 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences Opens Innovation Center in Washington", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/cytek-biosciences-opens-innovation-center-212308044.html", "source_name": "MT Newswires", "published_at": "2026-07-15T21:23:08+00:00", "published_display": "15 Jul 2026 21:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek\u2019s Bellevue center brings labs and training under one roof", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNOG8tX2ttMHVpbHFWWGhES1RiQmJzcE9SeVQzNGxlZTBXNXJGaDhsQUlXUnpSUktfUTZjUmU0MkF1QmNtc0htRmxiOTVfMGZZeGJtQUZUTFJJdk9LRnhITVlRR2tRNDR2azJDOUxSdEstNHlTUENGTEZPQXJfZnZud0hGbnQ0d2JtaTdhM254cFBpQ0ZrTkNET3hGZV9mM3E5Yldzc3o3TDRtNkJ0S1lyeXo3VWQ5OHJpalBoOFVXbm0?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T21:00:00+00:00", "published_display": "15 Jul 2026 21:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek\u00ae Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement", "summary": "Cytek Biosciences has announced the opening of a new innovation center in Bellevue, Washington, relocating its Seattle-area operations. This facility is designed to support research and development, strengthen collaboration, and enhance customer engagement with dedicated R&D labo", "url": "https://ca.finance.yahoo.com/news/cytek-biosciences-opens-innovation-center-210000127.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-15T20:40:03", "published_display": "15 Jul 2026 20:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek's Valerie Barnett exits as Chief Legal Officer; consulting role agreed", "summary": "Valerie Barnett's role as Chief Legal Officer and Corporate Secretary at Cytek terminated on June 29, 2026. She subsequently entered into a severance and consulting agreement in July 2026, which includes a one-time lump sum payment, COBRA premiums, and specific terms for her cons", "url": "https://www.tradingview.com/news/tradingview:9e2a6f4cd69bc:0-cytek-s-valerie-barnett-exits-as-chief-legal-officer-consulting-role-agreed/", "source_name": "TradingView", "published_at": "2026-07-15T20:40:03", "published_display": "15 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "BlackRock (NYSE: CTKB) holds 7.2% \u2014 9.36M shares of Cytek Biosciences", "summary": "BlackRock, Inc. has filed an amended Schedule 13G/A, disclosing a beneficial ownership of 9,356,551 shares in Cytek Biosciences, Inc. (CTKB), which represents 7.2% of the outstanding common stock as of June 30, 2026. The filing indicates BlackRock holds sole voting power over 9,2", "url": "https://www.stocktitan.net/sec-filings/CTKB/schedule-13g-a-cytek-biosciences-inc-amended-passive-investment-discl-41070d3d66e8.html", "source_name": "Stock Titan", "published_at": "2026-07-08T15:41:24", "published_display": "08 Jul 2026 15:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences expands flow cytometry footprint amid growing immunology demand", "summary": "Cytek Biosciences is expanding its presence in advanced flow cytometry, driven by increasing demand from immunology and cell therapy research. The company's systems and reagents aim to make high-parameter single-cell analysis more accessible, allowing researchers to study complex", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cytek-biosciences-expands-flow-cytometry-footprint-amid-growing-immunology/69714952", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T16:17:00", "published_display": "07 Jul 2026 16:17", "sentiment": "positive", "sentiment_pct": 90, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CTKB - Cytek BioSciences Inc Latest SEC Filings", "summary": "This article provides a detailed financial overview and snapshot of Cytek BioSciences Inc. (CTKB), including its recent stock performance, key financial metrics, insider and institutional ownership, and analyst recommendations. It highlights various valuation ratios, sales and ea", "url": "https://finviz.com/stock?t=CTKB&ta=1&p=m&ty=lf&page=3", "source_name": "Finviz", "published_at": "2026-07-06T01:09:57", "published_display": "06 Jul 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Cytek Biosciences, Inc. (CTKB)", "summary": "This article analyzes the historical performance of investing $1,000 in Cytek Biosciences, Inc. (CTKB), a cell analysis solutions company. It details how such an investment would have fared over one year, highlighting a 35% return. The piece also provides an overview of Cytek Bio", "url": "https://www.stocktitan.net/tools/stock-return-calculator/CTKB", "source_name": "Stock Titan", "published_at": "2026-07-04T12:10:51", "published_display": "04 Jul 2026 12:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences explores growth paths as investors weigh long-term potential", "summary": "Cytek Biosciences (CTKB, US23284C1053) is a life sciences company developing advanced instruments for cell analysis, particularly focusing on multi-parameter flow cytometry systems. The article highlights that with a thin news cycle, investor attention is on the company's long-te", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cytek-biosciences-explores-growth-paths-as-investors-weigh-long-term/69682944", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T20:40:57", "published_display": "03 Jul 2026 20:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (NASDAQ: CTKB) adds Chief Legal Officer as reporting insider", "summary": "Cytek Biosciences (NASDAQ: CTKB) has filed an initial Form 3 insider ownership report for Ilan Feuchtwang, its new Chief Legal Officer and Secretary. This filing formally establishes Feuchtwang as a reporting insider but does not indicate any stock purchases, sales, or other tran", "url": "https://www.stocktitan.net/sec-filings/CTKB/form-3-cytek-biosciences-inc-initial-statement-of-beneficial-ownershi-b7bae4bae11c.html", "source_name": "Stock Titan", "published_at": "2026-07-01T01:39:45", "published_display": "01 Jul 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences Announces Chief Legal Officer Transition", "summary": "Cytek Biosciences announced that its Chief Legal Officer and Corporate Secretary, Valerie Barnett, will depart on June 29, 2026, by mutual agreement not related to company operations. An analyst rating for CTKB stock is a Buy with a $4.75 price target, though TipRanks' AI Analyst", "url": "https://www.theglobeandmail.com/investing/markets/stocks/CTKB-Q/pressreleases/3007081/cytek-biosciences-announces-chief-legal-officer-transition/", "source_name": "The Globe and Mail", "published_at": "2026-07-01T01:13:38", "published_display": "01 Jul 2026 01:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Cytek Biosciences, Inc. \u2013 NASDAQ:CTKB", "summary": "The article focuses on the \"Price to sales forward\" metric for Cytek Biosciences, Inc. (NASDAQ: CTKB). It appears to be a stub or a section within a larger financial data platform, likely TradingView, providing financial oversight for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-CTKB/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T01:09:57", "published_display": "30 Jun 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Cytek Biosciences, Inc. \u2013 NASDAQ:CTKB", "summary": "This article provides financial information for Cytek Biosciences, Inc. (NASDAQ: CTKB) focusing on its enterprise value to revenue forward metric. The content appears to be a financial data page from TradingView, displaying the company's stock market data and financial details wi", "url": "https://www.tradingview.com/symbols/NASDAQ-CTKB/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T18:09:54", "published_display": "29 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Cytek Biosciences, Inc. \u2013 NASDAQ:CTKB", "summary": "This article presents the \"Price to earnings forward\" value for Cytek Biosciences, Inc. (NASDAQ:CTKB) as part of its financial overview on the TradingView platform. It indicates the period, value, and change metrics for this financial indicator, noting that the data is provided b", "url": "https://www.tradingview.com/symbols/NASDAQ-CTKB/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T01:41:19", "published_display": "29 Jun 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Cytek Biosciences, Inc. \u2013 NASDAQ:CTKB", "summary": "The article discusses the Enterprise Value to EBIT (EV/EBIT) forward metric for Cytek Biosciences, Inc. (NASDAQ: CTKB). It appears to be an excerpt from a financial data platform, likely TradingView, presenting a specific financial ratio for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-CTKB/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T18:39:43", "published_display": "28 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Cytek Biosciences, Inc. \u2013 BOATS:CTKB", "summary": "The article focuses on the enterprise value to revenue forward metric for Cytek Biosciences, Inc. (CTKB) as listed on the Blue Ocean Alternative Trade System (BOATS). It presents financial overview, news, community insights, forecasts, and seasonal trends related to the company's", "url": "https://www.tradingview.com/symbols/BOATS-CTKB/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T00:11:14", "published_display": "28 Jun 2026 00:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CTKB Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a forecast for Cytek Biosciences, Inc. (CTKB) stock, including analyst price targets and ratings. It details current stock performance, historical highs and lows, and key financial metrics like revenue, earnings, and market capitalization. The article also ad", "url": "https://www.tradingview.com/symbols/NASDAQ-CTKB/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T01:39:51", "published_display": "27 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "8EQ Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides an overview of Cytek Biosciences, Inc. (8EQ) stock, including analyst price targets, financial estimates, and historical performance. It details the company's next earnings report date, past earnings and revenue figures, net income, and confirms that it does", "url": "https://www.tradingview.com/symbols/SWB-8EQ/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T16:11:22", "published_display": "26 Jun 2026 16:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences Removes Chief Legal Officer", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/cytek-biosciences-removes-chief-legal-095930122.html", "source_name": "MT Newswires", "published_at": "2026-06-26T09:59:30+00:00", "published_display": "26 Jun 2026 09:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences, Inc. Actuals & Estimates (NASDAQ:CTKB)", "summary": "This article provides an overview of Cytek Biosciences, Inc. (NASDAQ:CTKB) stock performance, financial data, and analyst forecasts. It covers current stock price, historical highs and lows, volatility, market capitalization, and upcoming earnings reports, along with frequently a", "url": "https://www.tradingview.com/symbols/NASDAQ-CTKB/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T09:39:51", "published_display": "26 Jun 2026 09:39", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences, Inc. Actuals & Estimates (SWB:8EQ)", "summary": "This article provides an overview of Cytek Biosciences, Inc. (SWB:8EQ) stock, including financial actuals and estimates for income, balance sheet, and cash flow. It also details analyst price targets, historical stock performance, upcoming earnings dates, and financial metrics li", "url": "https://www.tradingview.com/symbols/SWB-8EQ/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T04:11:22", "published_display": "26 Jun 2026 04:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences, Inc. Actuals & Estimates (GETTEX:8EQ)", "summary": "This article provides an overview of Cytek Biosciences, Inc. (GETTEX:8EQ) including its current stock price, market capitalization, financial performance, and analyst forecasts. The stock has shown recent growth, and analysts have set a price target range for its future performan", "url": "https://www.tradingview.com/symbols/GETTEX-8EQ/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T02:10:48", "published_display": "26 Jun 2026 02:10", "sentiment": "positive", "sentiment_pct": 61, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (NASDAQ: CTKB) legal chief exit detailed", "summary": "Cytek Biosciences (NASDAQ: CTKB) has", "url": "https://www.stocktitan.net/sec-filings/CTKB/8-k-cytek-biosciences-inc-reports-material-event-5f28d4ece0e4.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:10:48", "published_display": "25 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences' Valerie Barnett to Depart as Chief Legal Officer and Corporate Secretary", "summary": "Valerie Barnett will step down from her role as Chief Legal Officer and Corporate Secretary of Cytek Biosciences, effective June 29, 2026. The company stated that her departure is not due to any disagreement with its operations, policies, or practices. Specific details regarding ", "url": "https://www.tradingview.com/news/tradingview:24f7425a898c4:0-cytek-biosciences-valerie-barnett-to-depart-as-chief-legal-officer-and-corporate-secretary/", "source_name": "TradingView", "published_at": "2026-06-25T20:10:48", "published_display": "25 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences, Inc. Announces Termination of Valerie Barnett as Chief Legal Officer and Corporate Secretary, Effective June 29, 2026", "summary": "Cytek Biosciences, Inc. announced the termination of Valerie Barnett's position as Chief Legal Officer and Corporate Secretary, effective June 29, 2026. The company stated that Ms. Barnett's separation is not due to any disagreement with Cytek Biosciences' operations, policies, o", "url": "https://www.marketscreener.com/news/cytek-biosciences-inc-announces-termination-of-valerie-barnett-as-chief-legal-officer-and-corporat-ce7f5fd9de8df72c", "source_name": "www.marketscreener.com", "published_at": "2026-06-25T16:32:00", "published_display": "25 Jun 2026 16:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences, Inc.(NasdaqGS: CTKB) dropped from S&P Composite 1500", "summary": "Cytek Biosciences, Inc. (NasdaqGS: CTKB) has been removed from the S&P Composite 1500 index. The announcement was made on June 21, 2026, at 08:57 pm EDT. The article also provides recent news updates about Cytek Biosciences, including board appointments, product innovations, and ", "url": "https://www.marketscreener.com/news/cytek-biosciences-inc-nasdaqgs-ctkb-dropped-from-s-p-composite-1500-ce7f5cd3d888f124", "source_name": "www.marketscreener.com", "published_at": "2026-06-21T20:57:00", "published_display": "21 Jun 2026 20:57", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences Stockholders Back Board, Pay and Auditor", "summary": "Cytek Biosciences (CTKB) stockholders recently held their 2026 annual meeting, with strong investor participation. They re-elected three Class II directors, approved executive compensation, and ratified Deloitte & Touche LLP as the independent accounting firm, ensuring continuity", "url": "https://www.theglobeandmail.com/investing/markets/stocks/CTKB-Q/pressreleases/2523832/cytek-biosciences-stockholders-back-board-pay-and-auditor/", "source_name": "The Globe and Mail", "published_at": "2026-06-18T17:40:59", "published_display": "18 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (CTKB) Stock Sees Fair Value Falls After Analysts Cut Targets", "summary": "Cytek Biosciences (CTKB) has seen its modelled fair value and average analyst price target reduced due to high operating expenses and an EBITDA shortfall. Despite these cuts, some analysts maintain an Overweight rating citing attractive valuation and potential M&A interest, while", "url": "https://finance.yahoo.com/markets/stocks/articles/cytek-biosciences-ctkb-stock-sees-071438210.html", "source_name": "Market source", "published_at": "2026-06-17T07:39:19", "published_display": "17 Jun 2026 07:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (CTKB) CTO Yan Ming reports bona fide gift of shares", "summary": "Cytek Biosciences' Chief Technology Officer, Yan Ming, reported a bona fide gift of 135,892 shares of common stock. This transaction, indicated by a Form 4 filing, involved no monetary exchange ($0.00 price per share) and was a non-market transfer. Following the gift, Ming retain", "url": "https://www.stocktitan.net/sec-filings/CTKB/form-4-cytek-biosciences-inc-insider-trading-activity-6bacd6bf45ef.html", "source_name": "Stock Titan", "published_at": "2026-06-17T07:10:50", "published_display": "17 Jun 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences Inc (CTKB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Cytek Biosciences Inc (CTKB) as of FY2023. It categorizes revenue by business segments, showing that Biotechnology, pharmaceutical, distributor, and CRO contributed 57.93% and Academia and government contributed 42.07%. The r", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ctkb/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T04:40:25", "published_display": "17 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences shareholders elect directors and approve key proposals at annual meeting", "summary": "Cytek Biosciences (NASDAQ:CTKB) held its 2026 annual meeting where shareholders elected three Class II directors, approved executive compensation, and ratified Deloitte & Touche LLP as the independent auditor. The company, with a market cap of $526.9 million, is considered underv", "url": "https://www.investing.com/news/sec-filings/cytek-biosciences-shareholders-elect-directors-and-approve-key-proposals-at-annual-meeting-93CH-4745738", "source_name": "Investing.com", "published_at": "2026-06-17T03:10:50", "published_display": "17 Jun 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (CTKB) details 2026 shareholder meeting voting outcomes", "summary": "Cytek Biosciences (CTKB) reported the outcomes of its 2026 annual shareholder meeting held on June 10, 2026. A strong quorum of approximately 86.1% of eligible shares was established. Shareholders approved three director nominees and two additional proposals with significant \"for", "url": "https://www.stocktitan.net/sec-filings/CTKB/8-k-cytek-biosciences-inc-reports-material-event-ec785a496841.html", "source_name": "Stock Titan", "published_at": "2026-06-16T20:10:50", "published_display": "16 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Cytek Biosciences to participate at the Singular Research\u2019s Las Vegas Invitational Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cytek-biosciences-participate-singular-research-200500492.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T20:05:00+00:00", "published_display": "10 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cytek-biosciences-unveil-next-generation-210000892.html", "source_name": "GlobeNewswire", "published_at": "2026-06-02T21:00:00+00:00", "published_display": "02 Jun 2026 21:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Cytek Biosciences (CTKB) Margin Worsening With Q4 Loss Challenges Bullish Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek (CTKB) Q1 2026 Earnings Call Transcript", "summary": "", "url": "https://finance.yahoo.com/m/edd998bd-4d92-313e-9282-709e10d93df8/cytek-%28ctkb%29-q1-2026-earnings.html", "source_name": "Motley Fool", "published_at": "2026-05-08T14:32:37+00:00", "published_display": "08 May 2026 14:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOSlZ5Wnd3d0J3MEVfM0NlN0xnQWtvbHZzZDRSdE0yQkJmak1yUUdCdkdsbXN3VG1ON2MwREc2ZWF1Vk5YclJZY1JfVHZ1WWdkenZiYmk0cVBvMVhiN3JoSURNN1liSHdMSkk3dGdTOGNFUUEyS2ZRWUpZelJkVjAtSVowSk9BZ1JST2YzZ1p0NUZweDl1blF6c29rek9McGxCRzludUl3ZERUWERIZUtsQ3JINmRrOUlReVY1Rkhad3lWQXYxRm8yS25Tb0IyRHc?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOckd3NWNXeEhjRFRzNUdBSW56dS1jLXlBYk9yTi1fc2F2amFUXzdwblctcl9jYnhOaHVYaHpnODZoMWtReFM3bW9nVU0tTVhJOVZmbkNBMjRtV2VMSkZXQmxXMS1hNmlVcDIxSUZyME96OHhtQzA2Tk52X1ZKeEJhQmdGNnNobktnNEJQU2FSZFhwUXRfLUdnWmlyamhUM24y?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (CTKB) Stock Falls on Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOaUt1cWktdE9Hd2hUUHpPenlsSG1sVUZndFBuWklCRjE1Y2lnbXpmejR1YjRnLWFDdU9OQkFJb0lhWUo1cjI3Q0JMY0t3N3V1bWIwNmtXSlNaV3VSM2ZSMnRmMFdXRE5KbC1iN0hCWHk3Uzc3dlEyWUN5aUZuVkg1cGVuSEdQWlRsMjNRa0dwckNob3ZuVV80bA?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQRVFwYVZmYXc2V2NabEtkNlJtTGhIaTV2WXhEQk5rRnNQZVNBVDVKVlA1R1p5NFBqZE9sRExFUUExbC1pemlSamRyRU1DSUFCNEpiM2hwZjBTaHlZbFpjQXZBVmk1b1prazIyMlI2YXpHSnowRm5Zd3U3SlNiLVh3YWpEMEcyQ0Vrb2FkY0lqVDdiMnpVSWNBUW40emU1b3VDNjAwb2RrUl9rRkhKRG9GdFE0WjdablJNay1zLUJiRFRnVEFabmwwZWk5c2NvWUVSMWQ1S0VwYWpEdjNZa0kxQ2l4TXk?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences sets May 7 webcast for Q1 2026 results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOeXR1cjJLY0VXSDlrc2lBNlRlcGF3aGdHWi16djVlOE5iU1lCLTNJWHZZN1R6ZVJwTlZCcEpBTl80QjVkbHl6OURaN04tbHhNV0Z0Vk1kUlVEaVYxdUwyUG5Tb1FkVlZ3S3o5RkNuM3BmWkpOVmVDNFdGVExwdktXaTZ0bG5QZHRlamdxQXJzUW8wZ3hhaDloa2l4cXdoMjBucjFpWmFXdHJfRjBFMC1Ddy1oLTJ1d19mT3lwVUlsQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (CTKB) Inspiring Confidence With Aurora CS System Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNSnE0Yl90bl9rcktRb1ZsWTFvdE1WeEhpVHpWdDcyZUJNNjU3QUNLSHE0ZkxjMm5Zdzlzc0dpalpUSThaZDdsV1pmMjk1V0FTMjh0NENXQmY4eXM2Yk9XMnpqcHVTbVZZVEhsd3ZUQTdzMmlYUW91bnhqZm02QzJvYm11UjVXNnB0OUljOTYzalJKSUNaRWtXZk9aRGU2NWI4NVZydUZWVjVoX0dFTGdBY293?oc=5", "source_name": "Market source", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Nasdaq-listed biotech company Cytek boosts Singapore facility with US$3 million investment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxONUZ5VGY2dkRCbndxV0pXLXNpTFA5U09tNFhTbzdNM0dDSWVaY29wNGFIU3NhM3NxRGgyN1c0UURjU1ZQVHRUREQtYlpGLWJJa3ZPQllja2lLdkJmbm50c2pMeXRBdUh1X25USC1OUXlrYzBkMVhCbzdTaHBERVdWQW9MZWJOVmQycFhtMlFVcWFJckQ4djJWVzR5aG85ZE1oT0lWcTlONVNtQXd1SEhWR1drUGRERGQ3WEVPVC1WWElKLTRLc1FqSnZjTk5hTkRG?oc=5", "source_name": "The Business Times", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Cytek\u2019s new Singapore facility speeds cell analysis for Asia\u2019s labs", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOZE9vMC1WNHJycUlNWU5RZDNwYzRzNkE2RFJxNVZvYWVvX3pJQkxLZXI4cjJVVlpacVBjRDN4VDkzQ2dYMVNoemh0X2k4a3NOTWlHNkNiZi1nTTdGa1RzR1o3ekR3Ykl0TDlGNXJTUnFsdEpYdGtwaVplRXVuRFBWYmhQT2JzOHNoajRNR3VNajY5WC10U3phWllzVENhNzl1OVB1UHpBUXVGN0NIZjBLMXlKUzZFQXp5UE5Z?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Cytek Biosciences (CTKB) Story Is Shifting With New Targets And 2026 Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQU0U5RUVIdUVpOWpBNmtINlBzOU5abDVZVThqN3NVT1pyMnY5aE5LRGUxVVZLcGliUnAzYW5oZ0lCcDV3ckhVVzZjanBRVFo1aExJRVpzUkhzUGZWMThUbkp3SEViSktvd1pWNXdXV2R6SnlORXR2dTN6ZWZGdnVEaWhjeW9xXzd4Z1dF?oc=5", "source_name": "Market source", "published_at": "2026-03-08T08:00:00+00:00", "published_display": "08 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Share Price Is Still Matching Investor Opinion Despite 27% Slump", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-13T08:00:00+00:00", "published_display": "13 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences Named to TIME's 2026 America's Growth Leaders List | CTKB Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQS2JmN21yeVd0dXNFT3I0Z0RSMENUQklzbUlnVDRNUVdqcGZUc1VMcDVuM3FTRHBMQ1ozTng2WTVqRlFyaHRUdVowX19PWXNEejRIU0VkeDFJbVZ6Zmw0QkNVcDFfVGxBa2lrX3JCa2FrVEJSbEs0dllVc2ZnY0sxOXNYaVIyeGkyY2xreHpCX3pGV0Eyc3NRY0ZiU0J5RlZuT2psWnBzMnQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-11-12T08:00:00+00:00", "published_display": "12 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (CTKB) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBUbTNxMnQwZGMzcWtVMS1CUkYtMmVBOXExR2dIemJHWGNiNHVTaGtNal80Z3YwbGtsbThGcG5aRjAyMzVfWXlSWGlMUHFQZkd2WjJ3?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T20:10:33+00:00", "published_display": "24 Apr 2025 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Cytek Biosciences (Nasdaq: CTKB) sets severance and consulting terms", "summary": "Cytek Biosciences has detailed the separation terms for its former Chief Legal Officer and Corporate Secretary, Valerie Barnett, whose tenure ended on June 29, 2026. The agreement includes a one-time severance payment of $365,775.12 and COBRA premium coverage, with enhanced benef", "url": "https://www.stocktitan.net/sec-filings/CTKB/8-k-cytek-biosciences-inc-reports-material-event-48c14d036f06.html", "source_name": "Stock Titan", "published_at": "2026-07-16T03:40:03", "published_display": "16 Jul 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences Opens Innovation Center in Washington", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/cytek-biosciences-opens-innovation-center-212308044.html", "source_name": "MT Newswires", "published_at": "2026-07-15T21:23:08+00:00", "published_display": "15 Jul 2026 21:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek\u2019s Bellevue center brings labs and training under one roof", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNOG8tX2ttMHVpbHFWWGhES1RiQmJzcE9SeVQzNGxlZTBXNXJGaDhsQUlXUnpSUktfUTZjUmU0MkF1QmNtc0htRmxiOTVfMGZZeGJtQUZUTFJJdk9LRnhITVlRR2tRNDR2azJDOUxSdEstNHlTUENGTEZPQXJfZnZud0hGbnQ0d2JtaTdhM254cFBpQ0ZrTkNET3hGZV9mM3E5Yldzc3o3TDRtNkJ0S1lyeXo3VWQ5OHJpalBoOFVXbm0?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-15T21:00:00+00:00", "published_display": "15 Jul 2026 21:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek\u00ae Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement", "summary": "Cytek Biosciences has announced the opening of a new innovation center in Bellevue, Washington, relocating its Seattle-area operations. This facility is designed to support research and development, strengthen collaboration, and enhance customer engagement with dedicated R&D labo", "url": "https://ca.finance.yahoo.com/news/cytek-biosciences-opens-innovation-center-210000127.html", "source_name": "Yahoo! Finance Canada", "published_at": "2026-07-15T20:40:03", "published_display": "15 Jul 2026 20:40", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek's Valerie Barnett exits as Chief Legal Officer; consulting role agreed", "summary": "Valerie Barnett's role as Chief Legal Officer and Corporate Secretary at Cytek terminated on June 29, 2026. She subsequently entered into a severance and consulting agreement in July 2026, which includes a one-time lump sum payment, COBRA premiums, and specific terms for her cons", "url": "https://www.tradingview.com/news/tradingview:9e2a6f4cd69bc:0-cytek-s-valerie-barnett-exits-as-chief-legal-officer-consulting-role-agreed/", "source_name": "TradingView", "published_at": "2026-07-15T20:40:03", "published_display": "15 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BlackRock (NYSE: CTKB) holds 7.2% \u2014 9.36M shares of Cytek Biosciences", "summary": "BlackRock, Inc. has filed an amended Schedule 13G/A, disclosing a beneficial ownership of 9,356,551 shares in Cytek Biosciences, Inc. (CTKB), which represents 7.2% of the outstanding common stock as of June 30, 2026. The filing indicates BlackRock holds sole voting power over 9,2", "url": "https://www.stocktitan.net/sec-filings/CTKB/schedule-13g-a-cytek-biosciences-inc-amended-passive-investment-discl-41070d3d66e8.html", "source_name": "Stock Titan", "published_at": "2026-07-08T15:41:24", "published_display": "08 Jul 2026 15:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences expands flow cytometry footprint amid growing immunology demand", "summary": "Cytek Biosciences is expanding its presence in advanced flow cytometry, driven by increasing demand from immunology and cell therapy research. The company's systems and reagents aim to make high-parameter single-cell analysis more accessible, allowing researchers to study complex", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cytek-biosciences-expands-flow-cytometry-footprint-amid-growing-immunology/69714952", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T16:17:00", "published_display": "07 Jul 2026 16:17", "sentiment": "positive", "sentiment_pct": 90, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CTKB - Cytek BioSciences Inc Latest SEC Filings", "summary": "This article provides a detailed financial overview and snapshot of Cytek BioSciences Inc. (CTKB), including its recent stock performance, key financial metrics, insider and institutional ownership, and analyst recommendations. It highlights various valuation ratios, sales and ea", "url": "https://finviz.com/stock?t=CTKB&ta=1&p=m&ty=lf&page=3", "source_name": "Finviz", "published_at": "2026-07-06T01:09:57", "published_display": "06 Jul 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Cytek Biosciences, Inc. (CTKB)", "summary": "This article analyzes the historical performance of investing $1,000 in Cytek Biosciences, Inc. (CTKB), a cell analysis solutions company. It details how such an investment would have fared over one year, highlighting a 35% return. The piece also provides an overview of Cytek Bio", "url": "https://www.stocktitan.net/tools/stock-return-calculator/CTKB", "source_name": "Stock Titan", "published_at": "2026-07-04T12:10:51", "published_display": "04 Jul 2026 12:10", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences explores growth paths as investors weigh long-term potential", "summary": "Cytek Biosciences (CTKB, US23284C1053) is a life sciences company developing advanced instruments for cell analysis, particularly focusing on multi-parameter flow cytometry systems. The article highlights that with a thin news cycle, investor attention is on the company's long-te", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cytek-biosciences-explores-growth-paths-as-investors-weigh-long-term/69682944", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-03T20:40:57", "published_display": "03 Jul 2026 20:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (NASDAQ: CTKB) adds Chief Legal Officer as reporting insider", "summary": "Cytek Biosciences (NASDAQ: CTKB) has filed an initial Form 3 insider ownership report for Ilan Feuchtwang, its new Chief Legal Officer and Secretary. This filing formally establishes Feuchtwang as a reporting insider but does not indicate any stock purchases, sales, or other tran", "url": "https://www.stocktitan.net/sec-filings/CTKB/form-3-cytek-biosciences-inc-initial-statement-of-beneficial-ownershi-b7bae4bae11c.html", "source_name": "Stock Titan", "published_at": "2026-07-01T01:39:45", "published_display": "01 Jul 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences Announces Chief Legal Officer Transition", "summary": "Cytek Biosciences announced that its Chief Legal Officer and Corporate Secretary, Valerie Barnett, will depart on June 29, 2026, by mutual agreement not related to company operations. An analyst rating for CTKB stock is a Buy with a $4.75 price target, though TipRanks' AI Analyst", "url": "https://www.theglobeandmail.com/investing/markets/stocks/CTKB-Q/pressreleases/3007081/cytek-biosciences-announces-chief-legal-officer-transition/", "source_name": "The Globe and Mail", "published_at": "2026-07-01T01:13:38", "published_display": "01 Jul 2026 01:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Cytek Biosciences, Inc. \u2013 NASDAQ:CTKB", "summary": "The article focuses on the \"Price to sales forward\" metric for Cytek Biosciences, Inc. (NASDAQ: CTKB). It appears to be a stub or a section within a larger financial data platform, likely TradingView, providing financial oversight for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-CTKB/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-30T01:09:57", "published_display": "30 Jun 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Cytek Biosciences, Inc. \u2013 NASDAQ:CTKB", "summary": "This article provides financial information for Cytek Biosciences, Inc. (NASDAQ: CTKB) focusing on its enterprise value to revenue forward metric. The content appears to be a financial data page from TradingView, displaying the company's stock market data and financial details wi", "url": "https://www.tradingview.com/symbols/NASDAQ-CTKB/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T18:09:54", "published_display": "29 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Cytek Biosciences, Inc. \u2013 NASDAQ:CTKB", "summary": "This article presents the \"Price to earnings forward\" value for Cytek Biosciences, Inc. (NASDAQ:CTKB) as part of its financial overview on the TradingView platform. It indicates the period, value, and change metrics for this financial indicator, noting that the data is provided b", "url": "https://www.tradingview.com/symbols/NASDAQ-CTKB/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T01:41:19", "published_display": "29 Jun 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Cytek Biosciences, Inc. \u2013 NASDAQ:CTKB", "summary": "The article discusses the Enterprise Value to EBIT (EV/EBIT) forward metric for Cytek Biosciences, Inc. (NASDAQ: CTKB). It appears to be an excerpt from a financial data platform, likely TradingView, presenting a specific financial ratio for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-CTKB/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T18:39:43", "published_display": "28 Jun 2026 18:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Cytek Biosciences, Inc. \u2013 BOATS:CTKB", "summary": "The article focuses on the enterprise value to revenue forward metric for Cytek Biosciences, Inc. (CTKB) as listed on the Blue Ocean Alternative Trade System (BOATS). It presents financial overview, news, community insights, forecasts, and seasonal trends related to the company's", "url": "https://www.tradingview.com/symbols/BOATS-CTKB/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T00:11:14", "published_display": "28 Jun 2026 00:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CTKB Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a forecast for Cytek Biosciences, Inc. (CTKB) stock, including analyst price targets and ratings. It details current stock performance, historical highs and lows, and key financial metrics like revenue, earnings, and market capitalization. The article also ad", "url": "https://www.tradingview.com/symbols/NASDAQ-CTKB/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-27T01:39:51", "published_display": "27 Jun 2026 01:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "8EQ Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides an overview of Cytek Biosciences, Inc. (8EQ) stock, including analyst price targets, financial estimates, and historical performance. It details the company's next earnings report date, past earnings and revenue figures, net income, and confirms that it does", "url": "https://www.tradingview.com/symbols/SWB-8EQ/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T16:11:22", "published_display": "26 Jun 2026 16:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences Removes Chief Legal Officer", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/cytek-biosciences-removes-chief-legal-095930122.html", "source_name": "MT Newswires", "published_at": "2026-06-26T09:59:30+00:00", "published_display": "26 Jun 2026 09:59", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences, Inc. Actuals & Estimates (NASDAQ:CTKB)", "summary": "This article provides an overview of Cytek Biosciences, Inc. (NASDAQ:CTKB) stock performance, financial data, and analyst forecasts. It covers current stock price, historical highs and lows, volatility, market capitalization, and upcoming earnings reports, along with frequently a", "url": "https://www.tradingview.com/symbols/NASDAQ-CTKB/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T09:39:51", "published_display": "26 Jun 2026 09:39", "sentiment": "positive", "sentiment_pct": 61, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences, Inc. Actuals & Estimates (SWB:8EQ)", "summary": "This article provides an overview of Cytek Biosciences, Inc. (SWB:8EQ) stock, including financial actuals and estimates for income, balance sheet, and cash flow. It also details analyst price targets, historical stock performance, upcoming earnings dates, and financial metrics li", "url": "https://www.tradingview.com/symbols/SWB-8EQ/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T04:11:22", "published_display": "26 Jun 2026 04:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences, Inc. Actuals & Estimates (GETTEX:8EQ)", "summary": "This article provides an overview of Cytek Biosciences, Inc. (GETTEX:8EQ) including its current stock price, market capitalization, financial performance, and analyst forecasts. The stock has shown recent growth, and analysts have set a price target range for its future performan", "url": "https://www.tradingview.com/symbols/GETTEX-8EQ/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T02:10:48", "published_display": "26 Jun 2026 02:10", "sentiment": "positive", "sentiment_pct": 61, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (NASDAQ: CTKB) legal chief exit detailed", "summary": "Cytek Biosciences (NASDAQ: CTKB) has", "url": "https://www.stocktitan.net/sec-filings/CTKB/8-k-cytek-biosciences-inc-reports-material-event-5f28d4ece0e4.html", "source_name": "Stock Titan", "published_at": "2026-06-25T20:10:48", "published_display": "25 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences' Valerie Barnett to Depart as Chief Legal Officer and Corporate Secretary", "summary": "Valerie Barnett will step down from her role as Chief Legal Officer and Corporate Secretary of Cytek Biosciences, effective June 29, 2026. The company stated that her departure is not due to any disagreement with its operations, policies, or practices. Specific details regarding ", "url": "https://www.tradingview.com/news/tradingview:24f7425a898c4:0-cytek-biosciences-valerie-barnett-to-depart-as-chief-legal-officer-and-corporate-secretary/", "source_name": "TradingView", "published_at": "2026-06-25T20:10:48", "published_display": "25 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences, Inc. Announces Termination of Valerie Barnett as Chief Legal Officer and Corporate Secretary, Effective June 29, 2026", "summary": "Cytek Biosciences, Inc. announced the termination of Valerie Barnett's position as Chief Legal Officer and Corporate Secretary, effective June 29, 2026. The company stated that Ms. Barnett's separation is not due to any disagreement with Cytek Biosciences' operations, policies, o", "url": "https://www.marketscreener.com/news/cytek-biosciences-inc-announces-termination-of-valerie-barnett-as-chief-legal-officer-and-corporat-ce7f5fd9de8df72c", "source_name": "www.marketscreener.com", "published_at": "2026-06-25T16:32:00", "published_display": "25 Jun 2026 16:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences, Inc.(NasdaqGS: CTKB) dropped from S&P Composite 1500", "summary": "Cytek Biosciences, Inc. (NasdaqGS: CTKB) has been removed from the S&P Composite 1500 index. The announcement was made on June 21, 2026, at 08:57 pm EDT. The article also provides recent news updates about Cytek Biosciences, including board appointments, product innovations, and ", "url": "https://www.marketscreener.com/news/cytek-biosciences-inc-nasdaqgs-ctkb-dropped-from-s-p-composite-1500-ce7f5cd3d888f124", "source_name": "www.marketscreener.com", "published_at": "2026-06-21T20:57:00", "published_display": "21 Jun 2026 20:57", "sentiment": "negative", "sentiment_pct": 31, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences Stockholders Back Board, Pay and Auditor", "summary": "Cytek Biosciences (CTKB) stockholders recently held their 2026 annual meeting, with strong investor participation. They re-elected three Class II directors, approved executive compensation, and ratified Deloitte & Touche LLP as the independent accounting firm, ensuring continuity", "url": "https://www.theglobeandmail.com/investing/markets/stocks/CTKB-Q/pressreleases/2523832/cytek-biosciences-stockholders-back-board-pay-and-auditor/", "source_name": "The Globe and Mail", "published_at": "2026-06-18T17:40:59", "published_display": "18 Jun 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (CTKB) Stock Sees Fair Value Falls After Analysts Cut Targets", "summary": "Cytek Biosciences (CTKB) has seen its modelled fair value and average analyst price target reduced due to high operating expenses and an EBITDA shortfall. Despite these cuts, some analysts maintain an Overweight rating citing attractive valuation and potential M&A interest, while", "url": "https://finance.yahoo.com/markets/stocks/articles/cytek-biosciences-ctkb-stock-sees-071438210.html", "source_name": "Market source", "published_at": "2026-06-17T07:39:19", "published_display": "17 Jun 2026 07:39", "sentiment": "negative", "sentiment_pct": 38, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (CTKB) CTO Yan Ming reports bona fide gift of shares", "summary": "Cytek Biosciences' Chief Technology Officer, Yan Ming, reported a bona fide gift of 135,892 shares of common stock. This transaction, indicated by a Form 4 filing, involved no monetary exchange ($0.00 price per share) and was a non-market transfer. Following the gift, Ming retain", "url": "https://www.stocktitan.net/sec-filings/CTKB/form-4-cytek-biosciences-inc-insider-trading-activity-6bacd6bf45ef.html", "source_name": "Stock Titan", "published_at": "2026-06-17T07:10:50", "published_display": "17 Jun 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences Inc (CTKB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Cytek Biosciences Inc (CTKB) as of FY2023. It categorizes revenue by business segments, showing that Biotechnology, pharmaceutical, distributor, and CRO contributed 57.93% and Academia and government contributed 42.07%. The r", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ctkb/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T04:40:25", "published_display": "17 Jun 2026 04:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences shareholders elect directors and approve key proposals at annual meeting", "summary": "Cytek Biosciences (NASDAQ:CTKB) held its 2026 annual meeting where shareholders elected three Class II directors, approved executive compensation, and ratified Deloitte & Touche LLP as the independent auditor. The company, with a market cap of $526.9 million, is considered underv", "url": "https://www.investing.com/news/sec-filings/cytek-biosciences-shareholders-elect-directors-and-approve-key-proposals-at-annual-meeting-93CH-4745738", "source_name": "Investing.com", "published_at": "2026-06-17T03:10:50", "published_display": "17 Jun 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (CTKB) details 2026 shareholder meeting voting outcomes", "summary": "Cytek Biosciences (CTKB) reported the outcomes of its 2026 annual shareholder meeting held on June 10, 2026. A strong quorum of approximately 86.1% of eligible shares was established. Shareholders approved three director nominees and two additional proposals with significant \"for", "url": "https://www.stocktitan.net/sec-filings/CTKB/8-k-cytek-biosciences-inc-reports-material-event-ec785a496841.html", "source_name": "Stock Titan", "published_at": "2026-06-16T20:10:50", "published_display": "16 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences to participate at the Singular Research\u2019s Las Vegas Invitational Conference", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cytek-biosciences-participate-singular-research-200500492.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T20:05:00+00:00", "published_display": "10 Jun 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cytek-biosciences-unveil-next-generation-210000892.html", "source_name": "GlobeNewswire", "published_at": "2026-06-02T21:00:00+00:00", "published_display": "02 Jun 2026 21:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (CTKB) Margin Worsening With Q4 Loss Challenges Bullish Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-09T07:00:00+00:00", "published_display": "09 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek (CTKB) Q1 2026 Earnings Call Transcript", "summary": "", "url": "https://finance.yahoo.com/m/edd998bd-4d92-313e-9282-709e10d93df8/cytek-%28ctkb%29-q1-2026-earnings.html", "source_name": "Motley Fool", "published_at": "2026-05-08T14:32:37+00:00", "published_display": "08 May 2026 14:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences Reports First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxOSlZ5Wnd3d0J3MEVfM0NlN0xnQWtvbHZzZDRSdE0yQkJmak1yUUdCdkdsbXN3VG1ON2MwREc2ZWF1Vk5YclJZY1JfVHZ1WWdkenZiYmk0cVBvMVhiN3JoSURNN1liSHdMSkk3dGdTOGNFUUEyS2ZRWUpZelJkVjAtSVowSk9BZ1JST2YzZ1p0NUZweDl1blF6c29rek9McGxCRzludUl3ZERUWERIZUtsQ3JINmRrOUlReVY1Rkhad3lWQXYxRm8yS25Tb0IyRHc?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Beats Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOckd3NWNXeEhjRFRzNUdBSW56dS1jLXlBYk9yTi1fc2F2amFUXzdwblctcl9jYnhOaHVYaHpnODZoMWtReFM3bW9nVU0tTVhJOVZmbkNBMjRtV2VMSkZXQmxXMS1hNmlVcDIxSUZyME96OHhtQzA2Tk52X1ZKeEJhQmdGNnNobktnNEJQU2FSZFhwUXRfLUdnWmlyamhUM24y?oc=5", "source_name": "Market source", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (CTKB) Stock Falls on Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOaUt1cWktdE9Hd2hUUHpPenlsSG1sVUZndFBuWklCRjE1Y2lnbXpmejR1YjRnLWFDdU9OQkFJb0lhWUo1cjI3Q0JMY0t3N3V1bWIwNmtXSlNaV3VSM2ZSMnRmMFdXRE5KbC1iN0hCWHk3Uzc3dlEyWUN5aUZuVkg1cGVuSEdQWlRsMjNRa0dwckNob3ZuVV80bA?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQRVFwYVZmYXc2V2NabEtkNlJtTGhIaTV2WXhEQk5rRnNQZVNBVDVKVlA1R1p5NFBqZE9sRExFUUExbC1pemlSamRyRU1DSUFCNEpiM2hwZjBTaHlZbFpjQXZBVmk1b1prazIyMlI2YXpHSnowRm5Zd3U3SlNiLVh3YWpEMEcyQ0Vrb2FkY0lqVDdiMnpVSWNBUW40emU1b3VDNjAwb2RrUl9rRkhKRG9GdFE0WjdablJNay1zLUJiRFRnVEFabmwwZWk5c2NvWUVSMWQ1S0VwYWpEdjNZa0kxQ2l4TXk?oc=5", "source_name": "GlobeNewswire", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences sets May 7 webcast for Q1 2026 results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOeXR1cjJLY0VXSDlrc2lBNlRlcGF3aGdHWi16djVlOE5iU1lCLTNJWHZZN1R6ZVJwTlZCcEpBTl80QjVkbHl6OURaN04tbHhNV0Z0Vk1kUlVEaVYxdUwyUG5Tb1FkVlZ3S3o5RkNuM3BmWkpOVmVDNFdGVExwdktXaTZ0bG5QZHRlamdxQXJzUW8wZ3hhaDloa2l4cXdoMjBucjFpWmFXdHJfRjBFMC1Ddy1oLTJ1d19mT3lwVUlsQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (CTKB) Inspiring Confidence With Aurora CS System Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNSnE0Yl90bl9rcktRb1ZsWTFvdE1WeEhpVHpWdDcyZUJNNjU3QUNLSHE0ZkxjMm5Zdzlzc0dpalpUSThaZDdsV1pmMjk1V0FTMjh0NENXQmY4eXM2Yk9XMnpqcHVTbVZZVEhsd3ZUQTdzMmlYUW91bnhqZm02QzJvYm11UjVXNnB0OUljOTYzalJKSUNaRWtXZk9aRGU2NWI4NVZydUZWVjVoX0dFTGdBY293?oc=5", "source_name": "Market source", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nasdaq-listed biotech company Cytek boosts Singapore facility with US$3 million investment", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxONUZ5VGY2dkRCbndxV0pXLXNpTFA5U09tNFhTbzdNM0dDSWVaY29wNGFIU3NhM3NxRGgyN1c0UURjU1ZQVHRUREQtYlpGLWJJa3ZPQllja2lLdkJmbm50c2pMeXRBdUh1X25USC1OUXlrYzBkMVhCbzdTaHBERVdWQW9MZWJOVmQycFhtMlFVcWFJckQ4djJWVzR5aG85ZE1oT0lWcTlONVNtQXd1SEhWR1drUGRERGQ3WEVPVC1WWElKLTRLc1FqSnZjTk5hTkRG?oc=5", "source_name": "The Business Times", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Cytek\u2019s new Singapore facility speeds cell analysis for Asia\u2019s labs", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOZE9vMC1WNHJycUlNWU5RZDNwYzRzNkE2RFJxNVZvYWVvX3pJQkxLZXI4cjJVVlpacVBjRDN4VDkzQ2dYMVNoemh0X2k4a3NOTWlHNkNiZi1nTTdGa1RzR1o3ekR3Ykl0TDlGNXJTUnFsdEpYdGtwaVplRXVuRFBWYmhQT2JzOHNoajRNR3VNajY5WC10U3phWllzVENhNzl1OVB1UHpBUXVGN0NIZjBLMXlKUzZFQXp5UE5Z?oc=5", "source_name": "Stock Titan", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The Cytek Biosciences (CTKB) Story Is Shifting With New Targets And 2026 Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQU0U5RUVIdUVpOWpBNmtINlBzOU5abDVZVThqN3NVT1pyMnY5aE5LRGUxVVZLcGliUnAzYW5oZ0lCcDV3ckhVVzZjanBRVFo1aExJRVpzUkhzUGZWMThUbkp3SEViSktvd1pWNXdXV2R6SnlORXR2dTN6ZWZGdnVEaWhjeW9xXzd4Z1dF?oc=5", "source_name": "Market source", "published_at": "2026-03-08T08:00:00+00:00", "published_display": "08 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Share Price Is Still Matching Investor Opinion Despite 27% Slump", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxPV29xN1NTc1RZVTlPRVRJcFc4c2pFZlRqampxVWdhakoxY1pGMm9Tc2wza3NyQ3BWOUVTSzhkQVV0TmQ5b3g4NlpXUXZnWk9zcEdrZHJwRjQtQUZjVGlsVzYyMkJYOFVlbElveXNDTWpQdDdCMGQ0X205QW9pVlh6QUtwd2xMT0d0YWkzdFJXRDlGWjhoOFZHdjhLbjEycXNNSHR0ZHp2bWFSb2NHYmZJNHBtcF9makFUR09UZjFZWGFCaU43QXRlOVBQMXpybjdEQ09LcmpRcjhNR05OLUt3SFM0WkFLd9IB6wFBVV95cUxPZ19QcFlxS3ZBZkxHRmItbXZFTzdlT0ZUTElDX0tIUzZRbG9MckotRlJwOVZKTml4TFpQNXBnTmQxVHhEY1doenJrZ1dGQXhGeWVFVVdHcndYQnJKWDdKMnlMc0tuVGxjN0VUcmR6elpvakJNcGd2eHlLdFJwZGxDcW05NEZBTm9HN1l4Z3FPZjA5UjZmVFZTc1lzNU8zTVNBbnhrMzhyby1GZEkzcUlleVNVWUhDNEZEMDYwaEFPZVh2VjVFRGpEZnJ3ckVvVFlZMXhGQk5OOXllQTBHZ3c2WHVERzFvM2Rydnlj?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-13T08:00:00+00:00", "published_display": "13 Feb 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences Named to TIME's 2026 America's Growth Leaders List | CTKB Stock News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQS2JmN21yeVd0dXNFT3I0Z0RSMENUQklzbUlnVDRNUVdqcGZUc1VMcDVuM3FTRHBMQ1ozTng2WTVqRlFyaHRUdVowX19PWXNEejRIU0VkeDFJbVZ6Zmw0QkNVcDFfVGxBa2lrX3JCa2FrVEJSbEs0dllVc2ZnY0sxOXNYaVIyeGkyY2xreHpCX3pGV0Eyc3NRY0ZiU0J5RlZuT2psWnBzMnQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2025-11-12T08:00:00+00:00", "published_display": "12 Nov 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cytek Biosciences (CTKB) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBUbTNxMnQwZGMzcWtVMS1CUkYtMmVBOXExR2dIemJHWGNiNHVTaGtNal80Z3YwbGtsbThGcG5aRjAyMzVfWXlSWGlMUHFQZkd2WjJ3?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T20:10:33+00:00", "published_display": "24 Apr 2025 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 94, "total_relevant": 60, "sentiment_summary": {"positive": 7, "negative": 4, "neutral": 49, "score": 52, "total": 60, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 15.4, "count": 28}, {"event": "earnings", "label": "Earnings", "weight": 12.79, "count": 26}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 7, "negative_events": 4}, "market_context": {"has_market_context": true, "latest_close": 4.62, "latest_week": "2026-07-10", "one_week_move": 0.7, "four_week_move": 16.7, "twelve_week_move": 0.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.313607, "market_dynamics_buy_signal": false, "relative_strength": -10.020001, "fair_value_gap": -14.8, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 45.6558, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.7% over one week, +16.7% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 49, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 13}, {"label": "TradingView", "count": 12}, {"label": "Stock Titan", "count": 11}, {"label": "GlobeNewswire", "count": 4}, {"label": "MT Newswires", "count": 2}, {"label": "The Globe and Mail", "count": 2}, {"label": "www.marketscreener.com", "count": 2}, {"label": "simplywall.st", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 49}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 28}, {"label": "Earnings", "count": 26}, {"label": "Analyst action", "count": 4}, {"label": "Macro sensitivity", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "49", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.7% over one week, +16.7% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Cytek Biosciences (Nasdaq: CTKB) sets severance and consulting terms"}], "updated_at": "2026-07-16T10:54:08.004101+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}